Researchers Say That If The Therapy Works As Well As It Does In Mice, We May Start Treating Alzheimer’s Effectively

Date March 29, 2018

Despite the record-breaking levels of funding spent on last-ditch attempts to prevent Alzheimer's, we all become as helpless as blind kittens the moment this diagnosis is made. But are we really as desperate as we're inclined to believe?

Naeblys / Shutterstock.com

Before we find out, let's gain an insight into the key genetics of this disease.

Photographee.eu / Shutterstock.com

The primary markers of Alzheimer's are the amyloid beta protein plaques, which start occurring as early as 20 years before the first symptoms of the disease start to show.

READ ALSO: Should People Feel Guilty About Sending Their Parents To A Nursing Home?

ESB Professional / Shutterstock.com

Researchers believe that these plaques consist of protein pieces that come from coat neuron cells. If these fragments cut short the connection keeping them together, enzymes occurring naturally prevent them from forming a clump.

Billion Photos / Shutterstock.com

Unfortunately, in the brains of people with Alzheimer's, this process cannot happen naturally.

BlueRingMedia / Shutterstock.com

Several recent clinical experiments tried to target the plaques using antibodies and resulted in unsustainable side effects.

Lighthunter / Shutterstock.com

However, a recent study carried out by Washington University tried to target a smaller protein segment contained within the plaques rather than the whole plaque. This protein segment is also referred to as APOE.

READ ALSO: "You Don't Know What This Means To Me!" 108-Year-Old Man Meets His Great-Great Grandson For The First Time

Lighthunter / Shutterstock.com

The gimmick of the recent experiment is that they used the antibody that matches APOE, not the whole plaque. The goal was also one-of-a-kind, as the scientists established a search-and-destroy rather than a containment purpose.

design36 / Shutterstock.com

Though no one expected the results to be impressive, the behavior of one of the antibodies was remarkable.

BlurryMe / Shutterstock.com

For as long as 6 weeks, the level of APOE proteins in the mice fell by 50% compared to prior-to-treatment phase. What's particularly good is that the antibody not only picked out the protein but also took the rest of the larger protein segments with it.

Atthapon Raksthaput / Shutterstock.com

Dr. Holtzman believes that if this therapy works in humans as well as it does in mice, it may finally provide the treatment we all have been searching for. It's the reason he says: "By removing plaques, if we start early enough we may be able to stop the changes to the brain that result in forgetfulness, confusion and cognitive decline."

It means that Alzheimer's disease may be left behind once and forever.

READ ALSO: Alzheimer's Patients Receive Baby Dolls For Therapy - Their Reaction Is Touching To The Core

This article is solely for informational purposes. Do not self-diagnose or self-medicate, and in all cases consult a certified healthcare professional before using any information presented in the article. The editorial board does not guarantee any results and does not bear any responsibility for harm that may result from using the information provided in the article.